Trade

Bharat Immunologicals & Biologicals Corporation Ltd share price

High risk
  • 47%Low risk
  • 47%Moderate risk
  • 47%Balanced risk
  • 47%High risk
  • 47%Extreme risk
  • ₹16.82(-1.87%)
    June 11, 2026 15:41:27 PM IST
    • NSE
    • BSE
  • Vol : 20.69 K (NSE + BSE)
    Last 20 day avg : 13.71 K

Bharat Immunologicals & Biologicals Corporation Ltd is trading -1.87% lower at Rs 16.82 as compared to its last closing price. Bharat Immunologicals & Biologicals Corporation Ltd has been trading in the price range of 17.35 & 16.66. Bharat Immunologicals & Biologicals Corporation Ltd has given -14.60% in this year & -0.75% in the last 5 days. The company posted a net profit of -4.92 Crores in its last quarter.Listed peers of Bharat Immunologicals & Biologicals Corporation Ltd include Cipla (0.49%), Sun Pharmaceutical Industries (0.65%), Dr Reddy's Laboratories (0.26%).The Mutual Fund holding in Bharat Immunologicals & Biologicals Corporation Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Bharat Immunologicals & Biologicals Corporation Ltd was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jun 11, 2026, 01:54 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.74
    Low volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.86
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
16.66
Highest
17.35
52 week range
Lowest
14.10
Highest
26.44
Bharat Immunologicals & Biologicals Corporation Ltd Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Cipla
Neutral
1,383.000.491,12,019.9822.953.870.870.81
Sun Pharmaceutical Industries
Neutral
1,798.800.654,31,377.0336.245.770.920.50
Dr Reddy's Laboratories
Neutral
1,275.050.261,06,242.5318.633.140.632.34
Divi's Laboratories
Bullish
6,672.000.501,76,838.2978.6111.520.460.01
Torrent Pharmaceuticals
Bullish
4,589.802.831,55,690.9967.3217.10.8317.62
Bharat Immunologicals & Biologicals Corporation Ltd Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2024-08-16General Purpose.
2024-03-08Others
2023-10-31Quarterly Results
2023-04-24Audited Results
2023-02-09Quarterly Results
About the company Bharat Immunologicals & Biologicals Corporation Ltd
  • IndustryBiotechnology & Drugs
  • ISININE994B01014
  • BSE Code524663
  • NSE Code
Bharat Immunologicals and Biologicals Corporation Limited is an India-based biotechnology company. The Company is primarily engaged in the manufacture of oral polio vaccine, zinc tablet, and diarrhea management kit. It operates under various segment, namely oral polio vaccine, zinc tablets, BIB VIT, and BIBSANIT. It is also focused on manufacturing Ready to Use Therapeutic Food (RUTF), which is used for the treatment of malnourishment among various acute malnourished children. The Company is switched over to bivalent oral polio vaccine (bOPV) from trivalent oral polio vaccine (tOPV). It is also diversified into plasma-derived medicines and Oral Cholera vaccines. The Company's manufacturing unit is located at Village Chola, Bulandshahr, Uttar Pradesh, India.
  • Management Info
  • Sanjay MishraManaging Director, Executive Director
  • Sandip LalCompany Secretary
Bharat Immunologicals & Biologicals Corporation Ltd Share Price FAQs

Bharat Immunologicals & Biologicals Corporation Ltd is trading at 16.82 as on Thu Jun 11 2026 10:11:27. This is -1.87% lower as compared to its previous closing price of 17.14.

The market capitalization of Bharat Immunologicals & Biologicals Corporation Ltd is 72.63 Cr as on Thu Jun 11 2026 10:11:27.

The 52 wk high for Bharat Immunologicals & Biologicals Corporation Ltd is 26.44 whereas the 52 wk low is 14.10

Bharat Immunologicals & Biologicals Corporation Ltd can be analyzed on the following key metrics -

  • TTM P/E:
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.96

Bharat Immunologicals & Biologicals Corporation Ltd reported a net profit of -17.06 Cr in 2023.

Quick Links
EQUITY QUICK LINKS
Bharat Immunologicals & Biologicals Corporation Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Bharat Immunologicals & Biologicals Corporation Ltd share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.